New daily pill could help shed pounds without injections

NCT ID NCT06953063

Completed Disease control Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new daily pill called DA-302168S in 250 overweight or obese adults. The pill works like a natural hormone to control appetite. Researchers measured weight loss and side effects over 16 weeks. The goal is to see if this pill is a safe and effective option for weight management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DA-302168S (a daily pill that mimics a natural hormone to help control appetite and weight)
What this could lead to: If successful, this could lead to a new once-daily pill for weight management in people with obesity or overweight.
What could go wrong: This is an early Phase 2 trial with only 250 participants, so results may not apply to everyone. The pill may cause side effects or fail to show meaningful weight loss compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVERWEIGHT AND OBESITY

Contacts and locations

Locations

Peking University People's Hospital

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.